A phase I, single center, open label, randomized, single-dose, five-way crossover study to compare the pharmacokinetics of NP 101 (sumatriptan iontophoretic transdermal patch) with three formulations of Imitrex in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 25 Apr 2012
At a glance
- Drugs Sumatriptan; Sumatriptan; Sumatriptan; Sumatriptan
- Indications Migraine
- Focus Pharmacokinetics
- Sponsors NuPathe
- 30 Oct 2007 New trial record.